Market Overview and Current Landscape The global healthcare sector is witnessing significant evolution in the Nontuberculous Mycobacterial Infections Treatment Market, driven by escalating infection rates and advancing medical technologies. These opportunistic pathogens, primarily affecting immunocompromised patients and those with underlying pulmonary conditions, represent a growing clinical challenge that demands sophisticated therapeutic interventions. Healthcare professionals increasingly… Read.